NCT00779740View on ClinicalTrials.gov

Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419)

PHASE3CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

February 1, 2005

Primary Completion Date

April 1, 2005

Study Completion Date

April 1, 2005

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

mometasone furoate

The dose will be 50 mcg as MF in one spray (100 µL) per nostril two times a day (morning and night) for 2 weeks. The daily dose of MF will be 200 mcg.

DRUG

mometasone furoate

The dose will be 50 mcg as MF in one spray (50 µL) per nostril two times a day (morning and night) for 2 weeks. The daily dose of MF will be 200 mcg.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00779740 - Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419) | Biotech Hunter | Biotech Hunter